Nitin Bajaj: this market rally has legs
Nitin Bajaj of Fidelity Asian Values believes the stockmarket rally will continue for some time yet.
After years of lagging growth stocks, some scepticism from investors about the recent rally in value is justified. However, Nitin Bajaj tells Citywire’s Gavin Lumsden that he believes the rally has legs. “In the year 2000, we were already six months into the style rotation out of growth into value and people were still questioning whether growth was going to come back... my sense is that this time, it’s going to be very similar.” He expects the trend to continue for “a few years at least”.
Bajaj has been running the Fidelity Asian Values (LSE: FAS) investment trust – which specialises in small-cap value stocks – since 2015. The fund holds around 100 stocks out of a possible 18,000 and Bajaj keeps around 20% of the fund in large stocks in order to “manage my liquidity”. In the past five years the share price has gained around 94%, underperforming the benchmark index at 114%, although as Lumsden notes, it has beaten its rivals in the same sector.
One trend Bajaj likes now is “toll roads of technology”. Rather than try to pick specific winners in the consumer product area, he buys the stocks that underpin the whole sector. For example, he owns chipmakers SK Hynix and Taiwan Semiconductor (TSMC). Whichever phone wins the most market share, the chips inside it will be made by one of these firms. “You’ll never get the same upside that you can in a product company because a product can become a hit, but a product will also, most likely fail over time. TSMC doesn’t fail.”
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
House prices rise 2.9% – will the recovery continue?
House prices grew by 2.9% on an annual basis in September. Will Budget policies and ‘higher-for-longer’ rates dent the recovery?
By Katie Williams Published
-
Nvidia earnings: what to expect
Nvidia announces earnings after market close on 20 November. What should investors expect from the semiconductor giant?
By Dan McEvoy Published
-
Investing in a dangerous world: key takeaways from the MoneyWeek Summit
If you couldn’t get a ticket to MoneyWeek’s summit, here’s an overview of what you missed
By MoneyWeek Published
-
DCC: a top-notch company going cheap
DCC has a stellar long-term record and promising prospects. It has been unfairly marked down
By Jamie Ward Published
-
How investors can use options to navigate a turbulent world
Explainer Options can be a useful solution for investors to protect and grow their wealth in volatile times.
By James Proudlock Published
-
Invest in Hilton Foods: a tasty UK food supplier
Hilton Foods is a keenly priced opportunity in an unglamorous sector
By Dr Matthew Partridge Published
-
HSBC stocks jump – is its cost-cutting plan already paying off?
HSBC's reorganisation has left questions unanswered, but otherwise the banking sector is in robust health
By Dr Matthew Partridge Published
-
Lock in an 11% yield with Sabre
Tips Sabre, a best-in-class company is undervalued due to low profits in the motor insurance industry. Should you invest?
By Rupert Hargreaves Published
-
Byju’s – the startling rise and fall
India’s educational technology start-up Byju's attracted big-name backers and soared to vertiginous heights during Covid. It has now plummeted. What happened?
By Jane Lewis Published
-
Shares in luxury goods companies take a hit – will they recover?
Luxury goods companies have run into trouble, and the odds of a rapid recovery have receded. What next?
By Dr Matthew Partridge Published